Trademark: 90818355
Word
EUKIVA
Status Date
Monday, July 29, 2024
Filing Date
Thursday, July 8, 2021
Published for Opposition
Tuesday, May 3, 2022
Abandoned Date
Monday, July 29, 2024
5 pharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis (FSGS); pharmaceutical preparations for the treatment of Immunoglobulin A Nephropathy (IgAN); pharmaceutical preparations for the treatment of Alport Syndrome
Jul 12, 2021
New Application Entered
Sep 16, 2021
New Application Office Supplied Data Entered
Mar 28, 2022
Assigned To Examiner
Mar 28, 2022
Approved For Pub - Principal Register
Apr 13, 2022
Notification Of Notice Of Publication E-Mailed
May 3, 2022
Published For Opposition
May 3, 2022
Official Gazette Publication Confirmation E-Mailed
Jun 28, 2022
Noa E-Mailed - Sou Required From Applicant
Dec 23, 2022
Sou Teas Extension Received
Dec 23, 2022
Sou Extension 1 Filed
Dec 23, 2022
Sou Extension 1 Granted
Dec 27, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 27, 2023
Sou Teas Extension Received
Jun 27, 2023
Sou Extension 2 Filed
Jun 27, 2023
Sou Extension 2 Granted
Jun 29, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 29, 2024
Abandonment - No Use Statement Filed
Dec 14, 2023
Sou Teas Extension Received
Dec 14, 2023
Sou Extension 3 Filed
Dec 14, 2023
Sou Extension 3 Granted
Dec 16, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 29, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Trademark Alertz updated from USPTO on 2030-01-24
